Likewise, the hyper phosphorylation of tau at Ser396 was discernible in synaptic-enriched fractions of DLB, AD, and PD brains [147], while α-synuclein genetic variability has been shown to modulate neurofibrillary tau pathology [148]. This evidence concerns the gene MAPT and Alzheimer disease.